OptiAge Level 2

OptiAge Level 2 is a combination of cell-protecting and energizing ingredients important for optimal aging. PrimaVie is a Himalayan shilajit fulvic acid complex clinically shown to increase high-energy ATP levels in the body. Ubiquinol is a bioavailable reduced form of coenzyme Q10 that plays protective and energy metabolism roles in mitochondria of cells. R-alpha lipoic acid is the "Universal Antioxident" that works in virtually every tissue of the body and recycles other antioxidants.*
***** 5.0 Stars
SAVINGS ALERT!
Save 10% on this order & all future orders when you Upgrade To VIP AutoRefill
Learn More
With VIP AutoRefill you save 10% on this order and 10% on all future orders!
Learn More

The Himalayan secret for energetic aging

Are you using OptiAge Level 1 to stay younger and healthier for longer?*
 
But you need more energy?
 
Caffeine and guarana may give you a quick fix.  But there's a hidden price to pay …
 
Stimulants force your adrenal glands to pump out hormonal energy.  But do nothing to replace what you've used.  And one day you will run out.
 
For thousands of years, Ayurvedic medicine has been using Shilajit – a rare organic substance from the Himalayas.  It's rich in trace minerals, humic acid and fulvic acid.
 
Shilajit boosts your energy by increasing ATP levels – there's no adrenal robbery.  What's more, it also:
  • Provide antioxidant protection for mitochondria - your body’s cellular-energy powerhouses.*
  • Improves energy and increases performance during exercise.*
And it may help prevent the fine lines, wrinkles and sagging skin associated with aging by or turning on the genes responsible for collagen synthesis.*
 
Every OptiAge Level 2 capsule contains 200mg of this natural, energy-giving substance.*  But that's not all …
 
You also get 50mg of Ubiquinol – one of the most bioavailable (usable by the body) forms of CoQ10.  Found throughout your body it's an important anti-oxidant nutrient.*  It:
  • Supports healthy blood pressure, glucose and cholesterol levels.*
  • Improves your exercise performance, recovery times and VO2 max (a mark of how fit you are).*
  • Has anti-inflammatory effects.*
And – like Shilajit – supports your mitochondrial health.  In fact, they work in synergy, with Shilajit extending CoQ10's effects.*
 
Finally, OptiAge Level 2 contains 50mg of R-Alpha-Lipoic acid.  Known as the Universal Antioxidant, Alpha-Lipoic acid is effective throughout your body.  And it helps recycle all other antioxidants.*
 
So if you're using OptiAge Level 1 to stay younger and healthier for longer … and want more energy...
 
 … why not give OptiAge Level 2 a try?*
 
If you don't agree it's worth every cent of your purchase price, we'll give you your money back – no questions asked.

Serving Size: 1 Veg Capsule

Servings Per Container: 30

Directions: Adults take 1 capsule daily.

Ingredient
Amount
% DV
Shilajit fulvic acid complex (PrimaVie®†)
200 mg
*
Coenzyme Q10 (as ubiquinol)   (Kaneka Ubiquinol™^)
50 mg
*
R-alpha lipoic acid
50 mg
*

*Daily Value (DV) not established.

Other Ingredients: Hypromellose, rice flour, stearic acid and silica.

Contains: no egg, milk, peanuts tree nuts, shellfish, fish, soy, wheat, gluten, sugar, or preservatives.

†PrimaVie® is a registered trademark of Natreon, Inc. under patents 7.250,181; 6.969.612; 6,440,436; 6,558,712; 8.894.993 and other pending patents

^Q+®, Kaneka Ubiquinol™ and the quality seal™ are registered or pending trademarks of Kaneka Corp.

GMP

  1. Bresolin N, Doriguzzi C, Ponzetto C, Angelini C, Moroni I, Castelli E, Cossutta E, Binda A, Gallanti A, Gabellini S, et al. J Neurol Sci. 1990 Dec;100(1-2):70-8.
  2. Digiesi V, Cantini F, Oradei A, Bisi G, Guarino GC, Brocchi A, Bellandi F, Mancini M, Littarru GP. Mol Aspects Med. 1994;15 Suppl:s257-63.
  3. Sobreira C, Hirano M, Shanske S, Keller RK, Haller RG, Davidson E, Santorelli FM, Miranda AF, Bonilla E, Mojon DS, Barreira AA, King MP, DiMauro S. Neurology. 1997 May;48(5):1238-43.
  4. Ylikoski T, Piirainen J, Hanninen O, Penttinen J. Mol Aspects Med. 1997;18 Suppl: S283-90.
  5. Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE. Clin Cancer Res. 1996 Mar;2(3):483-91.
  6. Breithaupt-Grögler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
  7. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. J Hum Hypertens. 1999 Mar;13(3):203-8.
  8. Konrad T, Vicini P, Kusterer K, Höflich A, Assadkhani A, Böhles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. Diabetes Care. 1999 Feb;22(2):280-7.
  9. Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Free Radic Biol Med. 1999 Aug;27(3-4):309-14.
  10. Bonetti A, Solito F, Carmosino G, Bargossi AM, Fiorella PL. J Sports Med Phys Fitness. 2000 Mar;40(1):51-7.
  11. Kaikkonen J, Tuomainen TP, Nyyssonen K, Salonen JT. Free Radic Res. 2002 Apr;36(4):389-97.
  12. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.
  13. Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28.
  14. Biswas TK, Pandit S, Mondal S, Biswas SK, Jana U, Ghosh T, Tripathi PC, Debnath PK, Auddy RG, Auddy B. Andrologia. 2010 Feb;42(1):48-56.
  15. Porasuphatana S, Suddee S, Nartnampong A, Konsil J, Harnwong B, Santaweesuk A. Asia Pac J Clin Nutr. 2012;21(1):12-21.
  16. Keith DJ, Butler JA, Bemer B, Dixon B, Johnson S, Garrard M, Sudakin DL, Christensen JM, Pereira C, Hagen TM. Pharmacol Res. 2012 Sep;66(3):199-206.
  17. Muraki A, Miyashita K, Mitsuishi M, Tamaki M, Tanaka K, Itoh H. J Appl Physiol (1985). 2012 Aug;113(3):479-86.
  18. Failla ML, Chitchumroonchokchai C, Aoki F. J Agric Food Chem. 2014 Jul 23;62(29):7174-82.
  19. Stohs SJ. Phytother Res. 2014 Apr;28(4):475-9.
  20. Packer L, Witt EH, Tritschler HJ. Free Radic Biol Med. 1995 Aug;19(2):227-50.
  21. Biewenga GP, Haenen GR, Bast A. Gen Pharmacol. 1997 Sep;29(3):315-31.
  22. Burke BE, Neuenschwander R, Olson RD. South Med J. 2001 Nov;94(11):1112-7.
  23. Caso G, Kelly P, McNurlan MA, Lawson WE. Am J Cardiol. 2007 May 15;99(10):1409-12.
  24. Kumar MR, Reddy AG, Anjaneyulu Y, Reddy GD. Toxicol Int. 2010 Jul;17(2):45-8. 
  25. Ansar H, Mazloom Z, Kazemi F, Hejazi N. Saudi Med J. 2011 Jun;32(6):584-8.
  26. Hermann R, Mungo J, Cnota PJ, Ziegler D. Clin Pharmacol. 2014 Nov 28;6:195-204.
OptiAge Level 1 OptiAge Level 1 and 2

Top